Gemseki has joined the Open COVID-19 Declaration, to provide our services and know-how to combat COVID-19 around the world.
The Open COVID-19 Declaration is an initiative in Japan to make participants’ intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing the impact of the disease. The initiative echoes the global Open COVID Pledge, which Gemseki joined as the first Japanese company as previously announced.
In accordance with the Gemseki declaration on COVID-19 as of March 30th, Gemseki has started to offer free partnering and licensing platform services to combat COVID-19 as announced on April 1st. Gemseki has already started to work on licensing and partnering of several drug candidates and technologies targeted to COVID-19 assets.
Gemseki is doing our utmost to end the COVID-19 pandemic.